Boston Scientific · 1 week ago
Cardiac Monitoring Tech II - $5,000 in Sign-on and Retention Bonuses
Boston Scientific is a company that tackles significant health industry challenges and values collaboration among its diverse employees. The Cardiac Monitoring Technician II is responsible for interpreting and reporting EKG data to assist physicians in diagnosing patients. This role requires onsite work and involves processing EKG data, documenting actions, and communicating vital information to the healthcare team.
Health CareMedicalMedical Device
Responsibilities
Process, analyze, interpret and edit EKG data
Collect recordings and patient symptoms as needed
Facilitate activation of EMS, if indicated
Accurately document actions taken within patient records
Facilitate orders for monitors and supplies
Obtain patient transmissions and related symptoms
Recognize abnormal cardiac rhythms/symptoms, and clearly communicate information to appropriate team member
Ensure customer enrollment is entered correctly
Address questions and educate patients, practices, and sales staff
Fax serious and critical reports to practices and hospitals as requested
Retain information that is job specific such as safety regulations and current policies and procedures
Other duties as assigned
Qualification
Required
2 years of experience with a high school diploma
CCT or CRAT certification
Preferred
Formal EKG education, whether a certificate from a school or third party certification
CET (Certified EKG Technician) – offered at some colleges and community colleges
CCT (Certified Cardiographic Technician)
CRAT (Certified Rhythm Analysis Technician)
Working Experience in a Hospital or IDTF after receiving their CET or other certifications
Hospital experience could be working in telemetry where they are interpreting what they see on the monitors and strips, then sharing that information with the doctors
Benefits
Eligible for yearly bonus of up to 4% of your yearly salary
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Recent News
Star Tribune
2026-01-20
2026-01-19
Boston Globe
2026-01-19
Company data provided by crunchbase